TMPRSS11D inhibitors are a class of chemical compounds designed to target and modulate the activity of the TMPRSS11D protein, also known as Transmembrane Protease Serine 11D. TMPRSS11D is a member of the transmembrane protease serine (TMPRSS) family, a group of enzymes that play critical roles in various physiological processes, particularly those related to the proteolytic cleavage and activation of proteins. TMPRSS11D, specifically, is primarily expressed in the human respiratory tract, including the bronchial epithelium, and it is involved in the regulation of protein processing and activation within the airway. Inhibitors of TMPRSS11D are developed to interfere with its enzymatic activity or other functions, affecting the proteolytic processing of target proteins in the respiratory tract.
The mechanisms by which TMPRSS11D inhibitors function can vary based on their chemical structures and binding properties. Some inhibitors may directly interact with TMPRSS11D, preventing its proteolytic cleavage of specific substrates or its activation of other proteins. Others may modulate the stability or conformation of TMPRSS11D, affecting its ability to cleave and activate target proteins. By inhibiting TMPRSS11D, these compounds impact the proteolytic events regulated by this enzyme within the respiratory tract, which may include the activation of viral glycoproteins or other proteins associated with respiratory infections. Ongoing research in this field aims to elucidate the precise mechanisms and downstream effects of TMPRSS11D inhibition, contributing to our understanding of its role in cellular biology and respiratory processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin can bind to RNA polymerase and inhibit RNA synthesis, potentially decreasing TMPRSS11D transcription. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine interferes with dopamine receptors and can influence various signaling pathways, possibly affecting TMPRSS11D expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to DNA and inhibits transcription of certain genes, which could include TMPRSS11D. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus binds to mTOR and inhibits its pathway, which may result in broad changes to gene expression, potentially affecting TMPRSS11D. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Spironolactone acts as an aldosterone antagonist and can influence gene expression, possibly including TMPRSS11D. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin causes premature chain termination during translation, which could result in decreased TMPRSS11D protein levels. | ||||||
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $186.00 $674.00 | 10 | |
Chetomin disrupts the function of hypoxia-inducible factor 1, which could downregulate TMPRSS11D expression in hypoxic conditions. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide has been shown to inhibit the transcription of various genes and may decrease TMPRSS11D expression. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin binds to Hsp90 affecting its function and potentially the stability of proteins involved in the regulation of TMPRSS11D expression. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin interferes with peptide elongation during protein synthesis, potentially affecting TMPRSS11D levels. | ||||||